cellmano peptide
Position:Home > About Us

Screening and identification of RhD antigen mimic epitopes from a phage display random peptide library for the serodiagnosis of

Published Time:2020-12-30Views:2606

Screening and identification of RhD antigen mimic epitopes from a phage display random peptide library for the serodiagnosis of haemolytic disease of the foetus and newborn

 

Published: 2018 Jan 16

Author: Jiao Wang, Jingjing Song, Shuimei Zhou, Yourong Fu, Jeffrey A. Bailey, and Changxin Shen            

Journal: Blood Transfusion   

 

Abstract

 

Background

Identification of RhD antigen epitopes is a key component in understanding the pathogenesis of haemolytic disease of the foetus and newborn. Research has indicated that phage display libraries are useful tools for identifying novel mimic epitopes (mimotopes) which may help to determine antigen specificity.

 

Materials and methods

We selected the mimotopes of blood group RhD antigen by affinity panning a phage display library using monoclonal anti-D. After three rounds of biopanning, positive phage clones were identified by enzyme-linked immunosorbent assay (ELISA) and then sent for sequencing and peptides synthesis. Next, competitive ELISA and erythrocyte haemagglutination inhibition tests were carried out to confirm the inhibitory activity of the synthetic peptide. To evaluate the diagnostic performance of the synthetic peptide, a diagnostic ELISA was examined.

 

Results

Fourteen of 35 phage clones that were chosen randomly from the titering plate were considered to be positive. Following DNA sequencing and translation, 11 phage clones were found to represent the same peptide - RMKMLMMLMRRK (P4) - whereas each of the other three clones represented a unique peptide. Through the competitive ELISA and erythrocyte haemagglutination inhibition tests, the peptide (P4) was verified to have the ability to mimic the RhD antigen. The diagnostic ELISA for P4 proved to be sensitive (82.61%) and specific (88.57%).

 

Discussion

This study reveals that the P4 peptide can mimic RhD antigen and paves the way for the development of promising targeted diagnostic and therapeutic platforms for haemolytic disease of the foetus and newborn.    Go to Article Link


image.png

Ask For Free Sample/Quotation

  • *Name:
  • *Product:
  • *Com.:
  • *E-mail:
  • *Content:
  • Code:
contact cellmano biotech
contact cellmano biotech

Chat

Go top